Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP752329.RAG8AF_Ma44TYD76lDx_vJ5scNr-MnKipZKrV49s8jh_0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP752329.RAG8AF_Ma44TYD76lDx_vJ5scNr-MnKipZKrV49s8jh_0130_assertion type Assertion NP752329.RAG8AF_Ma44TYD76lDx_vJ5scNr-MnKipZKrV49s8jh_0130_head.
- NP752329.RAG8AF_Ma44TYD76lDx_vJ5scNr-MnKipZKrV49s8jh_0130_assertion description "[The following percentages of these genes were found to be aberrantly methylated in gastric cancer samples; TFPI2 (80.9%), GPX3 (30.1%), DMRT1 (46.9%), GPX1 (16.7%), IGFBP6 (22.6%) and IRF7 (32.1%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP752329.RAG8AF_Ma44TYD76lDx_vJ5scNr-MnKipZKrV49s8jh_0130_provenance.
- NP752329.RAG8AF_Ma44TYD76lDx_vJ5scNr-MnKipZKrV49s8jh_0130_assertion evidence source_evidence_literature NP752329.RAG8AF_Ma44TYD76lDx_vJ5scNr-MnKipZKrV49s8jh_0130_provenance.
- NP752329.RAG8AF_Ma44TYD76lDx_vJ5scNr-MnKipZKrV49s8jh_0130_assertion SIO_000772 19195878 NP752329.RAG8AF_Ma44TYD76lDx_vJ5scNr-MnKipZKrV49s8jh_0130_provenance.
- NP752329.RAG8AF_Ma44TYD76lDx_vJ5scNr-MnKipZKrV49s8jh_0130_assertion wasDerivedFrom befree-20140225 NP752329.RAG8AF_Ma44TYD76lDx_vJ5scNr-MnKipZKrV49s8jh_0130_provenance.
- NP752329.RAG8AF_Ma44TYD76lDx_vJ5scNr-MnKipZKrV49s8jh_0130_assertion wasGeneratedBy ECO_0000203 NP752329.RAG8AF_Ma44TYD76lDx_vJ5scNr-MnKipZKrV49s8jh_0130_provenance.